Lv719
3390 积分 2025-02-12 加入
An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody–Drug Conjugates
18天前
已完结
Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis
18天前
已完结
Recent Advances in Peptide Linkers of Antibody–Drug Conjugates
18天前
已完结
Design of cathepsin-sensitive linkers for tumor-selective bioconjugate drug delivery
30天前
已完结
Exatecan Payload-Based Antibody-Drug Conjugates with a Short Hydrophilic Cleavable Linker
1个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
1个月前
已完结
Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human
1个月前
已完结
NQO1-responsive Trimethyl lock benzoquinone: A cleavable linker strategy for antibody-drug conjugates
1个月前
已完结
Benzyl Ammonium Carbamates Undergo Two‐Step Linker Cleavage and Improve the Properties of Antibody Conjugates
2个月前
已完结
Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC
2个月前
已完结
皖公网安备34019202002308
